Energy restriction combined with dipeptidyl peptidase-4 inhibitor exerts neuroprotection in obese male rats

• Main Authors: Hiranya Pintana, Pongpan Tanajak, Wasana Pratchayasakul, Piangkwan Sa-Nguanmoo, Titikorn Chunchai, Pattarapong Satjaritanun, Linlada Leelarphat, Nipon Chattipakorn, Siriporn C. Chattipakorn
• 格式: 雜誌
• 出版: 2018
• 主題: Medicine; Nursing
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84995467848&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/56009

Copyright © 2016 The Authors. Dipeptidyl peptidase-4 (DDP-4) inhibitors and energy restriction (ER) are widely used to treat insulin resistance and type 2 diabetes mellitus. However, the effects of ER or the combination with vildagliptin on brain insulin sensitivity, brain mitochondrial function, hi...